Forward P/S Multiple: Nevro (NVRO)

Nevro Corp. profitability is supported by stable demand, although geopolitics and sanctions create risks for supply chains. The issuer's forward P/S visualizes the market valuation, where 0.50 represents the current level of the metric. The business relies on lifetime implant maintenance, and the sector's independence from macroeconomics turns the company into a reliable defensive asset.

For Nevro Corp. (NVRO), which operates in the neurostimulator segment, the forward P/S reflects the market value relative to expected sales of pain treatment systems. By analyzing the trajectory of the forward P/S, an investor assesses the premium for future revenue growth in med-tech; the multiplier approaching the upper bounds of its historical range signals that the asset is overbought and indicates risks of a capital correction.